Newsletter Subscription
Subscribe to our newsletter & get updates in your inbox
We deliver integrated in vitro DMPK, PK, bioanalysis, and MetID solutions across multiple modalities, including small-molecule NCEs, peptides, PROTACs, and oligonucleotides.
Our scientists generate comprehensive metabolite profiles for NCEs and prodrugs, providing deep analytical insights through high-resolution mass spectrometry.
We also support CAR-T and cell therapy development and oligonucleotide design, alongside routine screening using biochemical and binding assays, IC50 determination, ELISA, and biomarker evaluation.